Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SolventumSOLV +0.48%28 EV-to-OCF is 94.93 as of Aug. 19, 2026, which is 261% above its 10-year median of 26.31. GuruFocus rates SOLV with a GF Score™ of 28/100. The stock has 7 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Solventum ranks worse than 94.59% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Solventum's Enterprise Value is $19,841 Mil.
Solventum's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $209 Mil. Therefore, Solventum's EV-to-OCF for today is 94.93.
The historical rank and industry rank for Solventum's EV-to-OCF or its related term are showing as below:
SOLV'
s EV-to-OCF Range Over the Past 10 Years
Min: 6.17 Med: 26.31 Max: 125.45
Current: 94.93
During the past 6 years, the highest EV-to-OCF of Solventum was 125.45. The lowest was 6.17. And the median was 26.31.
SOLV's EV-to-OCF is ranked worse than 94.59% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 7.78
vs SOLV: 94.93
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Solventum's share price for today is $87.87.
Solventum's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.180.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Solventum EV-to-OCF Related Terms
Solventum EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Solventum's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Solventum's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solventum EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Solventum's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Solventum's EV-to-OCF falls into.
Solventum's current Enterprise Value is $19,841 Mil.
Solventum's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $209 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solventum (SOLV) has a EV-to-OCF of 94.93 as of Aug. 19, 2026. This is 261% above median its historical median of 26.31. Over the past decade, Solventum's EV-to-OCF has ranged from 6.17 to 125.45. According to the industry distribution chart, Solventum ranks #805 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 94.6%.
Is Solventum's EV-to-OCF too high?
Solventum's current EV-to-OCF of 94.93 is 261% above median its 10-year median of 26.31. Over the past 10 years, this metric has ranged from a low of 6.17 to a high of 125.45. The Medical Devices & Instruments industry median EV-to-OCF is 7.78. Solventum's value of 94.93 is 1120.2% above this industry median. Based on the distribution chart, Solventum ranks #805 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Solventum has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Solventum's EV-to-OCF compare to COO and ALGN?
According to the Medical Devices & Instruments industry distribution chart, Solventum ranks #805 out of 851 companies for EV-to-OCF. This places Solventum in the lower half of its industry. The industry median EV-to-OCF is 7.78. Solventum's value of 94.93 is 1120.2% above this benchmark. Historically, Solventum's own EV-to-OCF has ranged from 6.17 to 125.45 over the past decade. While the company's 10-year median is 26.31 vs. the industry median of 7.78, Solventum has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.78, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Solventum's current EV-to-OCF of 94.93 is 1120.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solventum's current EV-to-OCF is 94.93, which is 261% above median its own 10-year median of 26.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solventum stock overvalued right now?
Solventum (SOLV) has a current EV-to-OCF of 94.93. The current EV-to-OCF is 94.93, which is 261% above median its 10-year median of 26.31 and 1120.2% above the Medical Devices & Instruments industry median of 7.78. Solventum's overall GF Score™ is 28/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Solventum (SOLV), the current EV-to-OCF is 94.93 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
28GF Score
Get the complete analysis for SOLV
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOLV has been successfully added to your 
